Dechra announced earlier today that it has received approval from the FDA for its pergolide tablets (Zygolide; Dechra) to ...
Zygolide ® is a first-to-market generic, peppermint-flavored pergolide tablet, offering enhanced features for horses ...
Corcept Therapeutics (CORT) leverages Korlym’s commercial success in hypercortisolism, generating $559.3M in nine-month 2025 ...
Cushing Syndrome is a relatively uncommon hormonal disorder that arises as a consequence of chronically elevated levels of cortisol in the body. Corti.
The festive period brought some unwanted post for both Sanofi and Corcept Therapeutics in the form of FDA rejections for the ...
The company was seeking approval for relacorilant as a treatment for patients with hypertension secondary to hypercortisolism ...
The U.S. Food and Drug Administration has declined to approve Corcept Therapeutics' drug for the treatment of a rare hormonal ...
Strong PALSONIFY U.S. Launch Execution Resulted in Unaudited and Preliminary Net Product Revenue of >$5 Million for ...
Amy Schumer has lost a considerable amount of weight over the past few months—over 50 pounds to date—and says that her weight loss journey was brought on by her Cushing Syndrome diagnosis, saying she ...
The FDA has issued a complete response letter for an oral selective glucocorticoid receptor antagonist under investigation ...
Comedian Amy Schumer, 44, has recently come clean about her struggle with Cushing’s syndrome, leading to a dramatic weight loss. Schumer's transformation has sparked conversation online, to which she ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback